NCT04423237View on ClinicalTrials.gov

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Iron Overload
Interventions
DRUG

Deferasirox

DEFERASIROX administered as per clinical practice and according to technical note

Trial Locations (1)

34137

IRCCS Burlo Garofolo, Trieste

All Listed Sponsors
collaborator

IRCCS Burlo Garofolo

OTHER

collaborator

University of Genova

OTHER

lead

University of Pisa

OTHER

NCT04423237 - Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT | Biotech Hunter | Biotech Hunter